Andrzej Andraczke

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Andrzej Andraczke

Earlier roles on record: Board Member at CNS Pharmaceuticals, Inc. (CNSP) until February 1, 2024. CNS Pharmaceuticals, Inc. reported in an 8-K filed February 2, 2024 that Andrzej Andraczke resigned as member of the Company's Board, effective February 1, 2024.

“On February 1, 2024, Andrzej Andraczke resigned as a member of the Company's Board.”

CNS Pharmaceuticals, Inc. Form 8-K, filed February 2, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Andrzej Andraczke's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

CNS Pharmaceuticals, Inc. (CNSP)
Board Member

Proxy statement

Start not stated–2024-02-01

Company network

Recorded roles and call appearances connecting this person to public companies.

CNS Pharmaceuticals, Inc.

CNSP

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: member of the Company's Board CNS Pharmaceuticals, Inc. (CNSP)
2024-02-01